Real world efficacy of dupilumab in switchers versus biological naive CRSwNP patients
Rhinology Journal · 01.06.2026
DOI: 10.4193/rhin26.041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rhinology Journal, online erschienen am 01.06.2026. Verfasst von J Lammens und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, KU Leuven, Leuven, Belgium.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Medicine, KU Leuven, Leuven, Belgium.
- KU Leuven Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Unit, Leuven, Belgium.
- Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
- Department of Otorhinolaryngology, University Hospital Brussels, Jette, Belgium.
- Department of Otorhinolaryngology, AZorg Aalst, Belgium.
- Department of Otorhinolaryngology, Jessa Ziekenhuis Hasselt.
Zitieren
APA
Lammens, J., Viskens, A., Verstappen, G., Halewyck, S., Verhaeghe, B., Cox, C., Hox, V., Lemmens, W., Rogister, F., Speleman, K., Vanderveken, O. M., & Hellings, P. W. (2026). Real world efficacy of dupilumab in switchers versus biological naive CRSwNP patients. Rhinology Journal, 0(0). https://doi.org/10.4193/rhin26.041
Vancouver
Lammens J, Viskens A, Verstappen G, Halewyck S, Verhaeghe B, Cox C, et al. Real world efficacy of dupilumab in switchers versus biological naive CRSwNP patients. Rhinology Journal. 2026;0(0). doi:10.4193/rhin26.041
BibTeX
@article{Lammens2026,
author = {Lammens, J and Viskens, A and Verstappen, G and Halewyck, S and Verhaeghe, B and Cox, C and Hox, V and Lemmens, W and Rogister, F and Speleman, K and Vanderveken, O M and Hellings, P W},
title = {Real world efficacy of dupilumab in switchers versus biological naive CRSwNP patients},
journal = {Rhinology Journal},
year = {2026},
volume = {0},
number = {0},
doi = {10.4193/rhin26.041}
}
EUVIMED